Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
mRNA | ATRA | FIMM | pan-cancer | AAC | -0.033 | 0.8 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.0075 | 0.8 |